Ushio (6925) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
6 Nov, 2026Executive summary
H1 FY2027 net sales rose 27.2% YoY to ¥103,538 million; operating profit increased 143.8% to ¥9,788 million, and parent-attributable profit reached ¥5,367 million.
Generative-AI-related demand, the acquired ams-OSRAM light-source business, improved product mix and structural reforms supported growth.
Financial highlights
Gross profit was ¥39,990 million vs. ¥29,627 million; SG&A was ¥30,201 million vs. ¥25,612 million.
Ordinary profit increased 92.2% to ¥9,674 million; basic EPS was ¥67.59 vs. ¥2.77.
Comprehensive income rose to ¥28,259 million from ¥4,439 million, including ¥24,767 million in valuation gains on available-for-sale securities.
Outlook and guidance
FY2027 guidance: net sales ¥220,000 million, operating profit ¥18,000 million, ordinary profit ¥18,000 million and parent-attributable profit ¥12,000 million; forecasts were revised Nov. 6.
Forecast YoY growth is 22.8% for sales, 50.5% for operating profit, 34.9% for ordinary profit and 50.1% for parent-attributable profit; EPS forecast is ¥151.16.
Annual dividend forecast remains ¥70 per share.
H2 lithography sales are expected to increase, but Q4-concentrated orders may slip into the next period; EUV revenue is expected to decline as the business winds down.
Forecasts assume USD/JPY 155 and EUR/JPY 180 for the full year; Q3 onward assumptions are ¥150/$ and ¥175/€.
Latest events from Ushio
- Profits and sales fell sharply, but guidance and dividend forecasts remain unchanged.6925
Q1 2025 - Net sales grew 0.8% but profits fell sharply; full-year profit outlook revised upward.6925
Q2 2025 - Profits and sales fell but exceeded forecasts; dividend and buybacks increased.6925
Q3 2025 - Operating profit dropped 32% on lower sales and inventory write-downs, but cash flow improved.6925
Q4 2025 - Net loss despite higher sales, with lamp business acquisition to support future growth.6925
Q1 2026 - Profits and sales declined YoY, but cash flow and select segment earnings improved.6925
Q2 2026 - Profits and sales rose, with strong Visual Imaging gains and a positive FY2026 outlook.6925
Q4 2026 - Operating profit rose despite lower sales, with strong gains in Visual Imaging and Life Sciences.6925
Q3 2026